Brent Pfeiffenberger
-

Century Therapeutics Expands Pipeline with Type 1 Diabetes Drug Candidate
Philadelphia-based Century Therapeutics is broadening its drug development pipeline with a new candidate aimed at treating Type 1 diabetes, an…
Brent Pfeiffenberger

Philadelphia-based Century Therapeutics is broadening its drug development pipeline with a new candidate aimed at treating Type 1 diabetes, an…